Eissler, N.; Altena, R.; Alhuseinalkhudhur, A.; Bragina, O.; Feldwisch, J.; Wuerth, G.; Loftenius, A.; Brun, N.; Axelsson, R.; Tolmachev, V.;
et al. Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy. Biomedicines 2024, 12, 1088.
https://doi.org/10.3390/biomedicines12051088
AMA Style
Eissler N, Altena R, Alhuseinalkhudhur A, Bragina O, Feldwisch J, Wuerth G, Loftenius A, Brun N, Axelsson R, Tolmachev V,
et al. Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy. Biomedicines. 2024; 12(5):1088.
https://doi.org/10.3390/biomedicines12051088
Chicago/Turabian Style
Eissler, Nina, Renske Altena, Ali Alhuseinalkhudhur, Olga Bragina, Joachim Feldwisch, Guido Wuerth, Annika Loftenius, Nikolai Brun, Rimma Axelsson, Vladimir Tolmachev,
and et al. 2024. "Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy" Biomedicines 12, no. 5: 1088.
https://doi.org/10.3390/biomedicines12051088
APA Style
Eissler, N., Altena, R., Alhuseinalkhudhur, A., Bragina, O., Feldwisch, J., Wuerth, G., Loftenius, A., Brun, N., Axelsson, R., Tolmachev, V., Sörensen, J., & Frejd, F. Y.
(2024). Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy. Biomedicines, 12(5), 1088.
https://doi.org/10.3390/biomedicines12051088
